ID
45803
Descripción
Principal Investigator: David Solit, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA MeSH: Carcinoma, Signet Ring Cell,Urinary Bladder Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001064 In this study, six plasmacytoid bladder cancers were analyzed by whole exome sequencing. The results show loss of the CDH1 gene in every sample and correlate with E-cadherin loss of expression by immunohistochemistry. A separate validation cohort of plasmacytoid samples showed loss of E-cadherin expression by CDH1 mutation or promoter hypermethylation.
Link
Palabras clave
Versiones (1)
- 23/6/23 23/6/23 - Chiara Middel
Titular de derechos de autor
David Solit, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Subido en
23 de junio de 2023
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs001064 Whole Exome Sequencing of Signet Ring/Plasmacytoid Variant Bladder Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age onset, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, primary tumor, metastasis, or transformed cell line, and primary tumor location.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age onset, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, primary tumor, metastasis, or transformed cell line, and primary tumor location.
C0680251 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,2])
C0205462 (UMLS CUI [1,3])
C0205419 (UMLS CUI [1,4])